BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33489885)

  • 1. Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.
    Vázquez R; Riveiro ME; Berenguer-Daizé C; O'Kane A; Gormley J; Touzelet O; Rezai K; Bekradda M; Ouafik L
    Front Oncol; 2020; 10():589218. PubMed ID: 33489885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
    Hay DL; Walker CS; Poyner DR
    Endocr Relat Cancer; 2011 Feb; 18(1):C1-14. PubMed ID: 21051558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
    Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
    Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion.
    Benyahia Z; Dussault N; Cayol M; Sigaud R; Berenguer-Daizé C; Delfino C; Tounsi A; Garcia S; Martin PM; Mabrouk K; Ouafik L
    Oncotarget; 2017 Feb; 8(9):15744-15762. PubMed ID: 28178651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad targeting of angiogenesis for cancer prevention and therapy.
    Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents.
    Jailani ABA; Bigos KJA; Avgoustou P; Egan JL; Hathway RA; Skerry TM; Richards GO
    Expert Opin Drug Discov; 2022 Aug; 17(8):839-848. PubMed ID: 35733389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance Mechanisms to Anti-angiogenic Therapies in Cancer.
    Haibe Y; Kreidieh M; El Hajj H; Khalifeh I; Mukherji D; Temraz S; Shamseddine A
    Front Oncol; 2020; 10():221. PubMed ID: 32175278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and Lymphangiogenesis.
    Benyahia Z; Gaudy-Marqueste C; Berenguer-Daizé C; Chabane N; Dussault N; Cayol M; Vellutini C; Djemli A; Nanni I; Beaufils N; Mabrouk K; Grob JJ; Ouafik L
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic effects of adrenomedullin in ischemia and tumor growth.
    Iimuro S; Shindo T; Moriyama N; Amaki T; Niu P; Takeda N; Iwata H; Zhang Y; Ebihara A; Nagai R
    Circ Res; 2004 Aug; 95(4):415-23. PubMed ID: 15242974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
    Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
    Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
    Siclari VA; Mohammad KS; Tompkins DR; Davis H; McKenna CR; Peng X; Wessner LL; Niewolna M; Guise TA; Suvannasankha A; Chirgwin JM
    Breast Cancer Res; 2014 Dec; 16(6):458. PubMed ID: 25439669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and Challenges in Tumor Anti-Angiogenic Therapies.
    Jászai J; Schmidt MHH
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates.
    Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG
    Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A; Folkman J
    Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenomedullin Up-regulates the Expression of Vascular Endothelial Growth Factor in Epithelial Ovarian Carcinoma Cells via JNK/AP-1 Pathway.
    Chen Q; Chen P; Pang X; Hu Y; Zhang Y
    Int J Gynecol Cancer; 2015 Jul; 25(6):953-60. PubMed ID: 26098087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin as a therapeutic target in angiogenesis.
    Deville JL; Salas S; Figarella-Branger D; Ouafik L; Daniel L
    Expert Opin Ther Targets; 2010 Oct; 14(10):1059-72. PubMed ID: 20846006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.